María Teresa Valero Griñán

The NANOKINOME project focusses on the development of nanosensors for drug target deconvolution. In particular, Teresa works on the development of a fluorescent and magnetic nanosensor to detect the different targets of promiscuous kinase inhibitors and other anticancer drugs with the final objective of avoiding those responsible for side effects. The project is divided in two phases: a first phase dedicated to the validation of the nanoprobe for target deconvolution and a second phase dedicated to the addition of several functional moieties for the improvement of the probe performance. The project, which has a duration of 24 months is funded by the TALENTIA POSTDOC FELLOWSHIP PROGRAM (267226).
"This project has received funding from the European Union¿s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 267226".